summary
Introduced
03/29/2021
03/29/2021
In Committee
06/23/2022
06/23/2022
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
192nd General Court
Bill Summary
For legislation relative to benzodiazepines and non-benzodiazepine hypnotics. Mental Health, Substance Use and Recovery.
AI Summary
This bill aims to strengthen regulations around benzodiazepines and non-benzodiazepine hypnotics, which are drugs primarily used to treat insomnia, anxiety, and other conditions. Key provisions include:
1. Defining "benzodiazepine" and "non-benzodiazepine hypnotic" in state law.
2. Requiring pharmacists to provide a cautionary label on prescriptions for these drugs, explaining the risks of long-term use.
3. Mandating the distribution of educational pamphlets about the risks of misuse, abuse, dependency, and addiction when dispensing these medications.
4. Prohibiting the refill of prescriptions for less than a 10-day supply of these drugs.
5. Requiring practitioners to obtain written informed consent from patients before prescribing these medications, which must include information on the risks.
6. Establishing a special commission to study safe protocols for discontinuing the use of these drugs and minimizing withdrawal symptoms.
Overall, the bill aims to increase awareness and oversight around the use of benzodiazepines and related sleep medications in order to address concerns about misuse, abuse, and addiction.
Committee Categories
Health and Social Services
Sponsors (5)
Last Action
Accompanied a study order, see S2995 (on 07/11/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://malegislature.gov/Bills/192/S1260 |
Bill | https://malegislature.gov/Bills/192/S1260.pdf |
Loading...